Author

Mila Arnaudova

Observed names: M. Arnaudova, MILA ARNAUDOVA

Observed institution: Military Medical Academy

OpenAlex ID: A5010591616

Correlation Between 180th Minute Glucose Measurement During Oral Glucose Tolerance Test and Insulin Secretion

2021 · T. Totomirova, M. Arnaudova · Metabolism · 2

900-P: HbA1c Is an Insufficient Glucose Control Assessment Tool in Type 1 and Type 2 Treated with Insulin

2020 · TZVETELINA TOTOMIROVA, MILA ARNAUDOVA, et al. · Diabetes · 2

EP732 - ECE_3081 - Insulin secretion assessment during oral glucose tolerance test

2026 · Tzvetelina Totomirova, Mila Arnaudova, et al. · European Journal of Endocrinology

PDF

1928-P: Continuous Glucose Monitoring as Assessment Tool for Diagnosis of Prediabetes State

2026 · TZVETELINA TOTOMIROVA, MILA ARNAUDOVA, et al. · Diabetes

714-P: Oral Glucose Tolerance Test or Continuous Glucose Monitoring for Assessment of Prediabetes State

2025 · TZVETELINA TOTOMIROVA, MILA ARNAUDOVA · Diabetes

Measurement of insulin secretion during oral glucose tolerance test for prediction of obesity treatment success

2025 · Tzvetelina Totomirova, Mila Arnaudova, et al. · Endocrine Abstracts

Blood glucose and insulin level during oral glucose tolerance test as predictors for treatment efficacy in obese patients

2024 · Tzvetelina Totomirova, Mila Arnaudova · Endocrine Abstracts

IDF23-0325 Effect of re-education in patients with diabetes on foot complication prevention

2024 · T. Totomirova, M. Arnaudova, et al. · Diabetes Research and Clinical Practice

SAT099 Should We Use HbA1c Or Continuous Glucose Monitoring (CGM) For Treatment Adjustment In Type 2 Diabetes Non-insulin Treated Patients?

2023 · Tzvetelina Totomirova, Mila Arnaudova · Journal of the Endocrine Society

PDF

Physical activity assessment is crucial for obesity risk prediction in adolescent patients

2023 · Tzvetelina Totomirova, Mila Arnaudova, et al. · Endocrine Abstracts

Correlation between Blood Glucose and Insulin Secretion during Oral Glucose Tolerance Test and Diabetes Risk in Obese Patients

2023 · Tzvetelina Totomirova, Mila Arnaudova, et al. · Metabolism

702-P: Short-Period CGM Data Are More Useful than HbA1c for Treatment Adjustment in Type 2 Diabetes Patients

2022 · TZVETELINA TOTOMIROVA, MILA ARNAUDOVA · Diabetes

Use of continuous glucose monitoring for treatment adjustment in type 2 diabetes patients

2022 · Tzvetelina Totomirova, Mila Arnaudova · Endocrine Abstracts

IDF21-0313 Effect of moderate doses vitamin D on polyneuropathy in type 2 diabetes patients

2022 · M. Arnaudova, T. Totomirova · Diabetes Research and Clinical Practice

PDF

Importance of Each Hour Glucose Measurement During Oral Glucose Tolerance Test and Correlation with Insulin Secretion

2022 · T. Totomirova, M. Arnaudova · Metabolism

623-P: Should We Continue Using HbA1c for Treatment Adjustment in Patients with Type 2 Diabetes?

2021 · TZVETELINA TOTOMIROVA, MILA ARNAUDOVA · Diabetes

Use of continuous glucose monitoring for control assessment in type 2 diabetes patients

2021 · Tzvetelina Totomirova, Mila Arnaudova, et al. · Endocrine Abstracts

HbA1c Is Not Potent Glucose Control Assessment Tool in Type 2 Diabetes Patients Treated With Insulin

2021 · Tzvetelina Totomirova, Mila Arnaudova · Journal of the Endocrine Society

946-P: HbA1c Is Already Not Enough for Glucose Control Assessment in Type 1 and Type 2 Diabetes

2019 · TZVETELINA TOTOMIROVA, IVONA DASKALOVA, et al. · Diabetes

897-P: Continuous Glucose Monitoring (CGM) in Management of Patients with Severe Traumatic Brain Injury

2019 · IVONA DASKALOVA, TZVETELINA TOTOMIROVA, et al. · Diabetes

Use of Continuous Glucose Monitoring Data for Defining Glucose Control in Insulin-Treated Patients

2018 · TZVETELINA TOTOMIROVA, IVONA DASKALOVA, et al. · Diabetes

Works count: 21

Citation count: 4

H-index: 2

I10-index: